SmallCaps
ASX:BGTMaterialsFertilizers & Agricultural Chemicals

Bio-Gene Technology Ltd

$0.019
Day Range
$0.019 – $0.019
52 Week Range
$0.016 – $0.061
Volume
5.00K
Avg Volume (10D)
29.54K
Market Cap
$8.32M

Price Chart

OHLC · volume · moving averages

$0.019-$0.014 (-42.42%)over 6M
Hi$0.045Lo$0.016
Price-sensitive newsVolumePrev close · 52W range

Market Statistics

Today's trading range

Open
$0.019
Previous Close
$0.019
Day High
$0.019
Day Low
$0.019
52 Week High
$0.061
52 Week Low
$0.016

Valuation

Fundamental multiples

Market Cap
8.32M
Shares Outstanding
438.06M
Price to Book
5.23

Trading Activity

Volume & order book

Volume
5.00K
Value Traded
95.00
Bid
$0.018 × 252,895
Ask
$0.019 × 23,071

Performance

Returns across timeframes

1 Day
11.11%
5 Day
11.11%
13 Week
-31.03%
52 Week
-4.76%
YTD
-13.04%

Technical Indicators

Momentum & moving averages

RSI (14)
45.76
50-Day SMA
$0.019
200-Day SMA
$0.027

— From the desk

Latest News

Bio-Gene Reports Strong Flavocide Results Against Ticks to Leading US Lyme Disease Conference
Industrials & Juniors

Bio-Gene Reports Strong Flavocide Results Against Ticks to Leading US Lyme Disease Conference

Bio-Gene Technology (ASX: BGT) has released new data confirming that its lead compound Flavocide delivers strong activity against ticks responsible for spreading Lyme disease in the United States. Presented by Purdue University researchers at the International Conference on Lyme Borreliosis and Other Tick-Borne Diseases in Chicago, the findings showed that Flavocide achieved more than 90% […]

Bio-Gene awarded $3m in US grants to develop insecticides for military use
Industrials & Juniors

Bio-Gene awarded $3m in US grants to develop insecticides for military use

Bio-Gene Technology (ASX: BGT) has been awarded $3 million in grants by the US Department of Defense to develop insecticide products to protect its workforce from threats posed by disease-carrying species including mosquitoes and ticks. The grants have been provided under the government’s Deployed Warfighter Protection research program. The program aims to identify and test […]

Bio-Gene signs public health control partnership with Clarke Mosquito Control
Industrials & Juniors

Bio-Gene signs public health control partnership with Clarke Mosquito Control

Just over three months since seeing its insecticide products pass US trials, agriculture technology development company Bio-Gene Technology (ASX: BGT) has unveiled a partnership with US-based Clarke Mosquito Control to develop its Flavocide and Qcide products for use in public health mosquito control in North, South and Central America. Clarke is currently the largest public […]

US trials confirm Bio-Gene’s Flavocide to be an effective control for mosquito-related diseases
Industrials & Juniors

US trials confirm Bio-Gene’s Flavocide to be an effective control for mosquito-related diseases

The results of collective US trials by Australian ag-tech development company Bio-Gene Technology (ASX: BGT) have confirmed the natural compound product Flavocide can control the Anopheles gambiae mosquito species which carries malaria and is increasingly resistant to commonly-used sprays. Conducted at Purdue University’s world-leading entomology faculty which specialises in vector control, the trials showed that […]